Kraus Stephen

CIK 00013620994 companiesLARCHMONT, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001362099

Recent Transactions

36 trades

Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−0→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Common Stock
2025-10-02−16,443→ 0 total
Disposition to Issuer
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2025-10-02−0→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Restricted Stock Units
2025-05-13−10,500→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2025-05-13+10,500→ 16,444 total
Award
NeueHealth, Inc.$NEUE
Restricted Stock Units
2024-05-13+10,500→ 10,500 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2024-05-12+4,755→ 5,944 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Restricted Stock Units
2024-05-12−4,755→ 0 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Common Stock
2023-05-13+95,109→ 95,109 total
Exercise/Conversion
NeueHealth, Inc.$NEUE
Restricted Stock Units
2023-05-13−95,109→ 0 total
Award
NeueHealth, Inc.$NEUE
Restricted Stock Units
2023-05-12+380,434→ 380,434 total
Award
NeueHealth, Inc.$NEUE
Series B Convertible Perpetual Preferred Stock
2022-10-17$1000.00/sh+8,500→ 0 total
Award
NeueHealth, Inc.$NEUE
Restricted Stock Units
2022-05-13+95,109→ 95,109 total
Conversion
NeueHealth, Inc.$NEUE
Common Stock
2021-06-28+0→ 0 total
Conversion
NeueHealth, Inc.$NEUE
Series B Preferred Stock
2021-06-28−0→ 0 total
Conversion
NeueHealth, Inc.$NEUE
Series C Preferred Stock
2021-06-28−0→ 0 total
Conversion
NeueHealth, Inc.$NEUE
Series D Preferred Stock
2021-06-28−0→ 0 total
Conversion
NeueHealth, Inc.$NEUE
Series A Preferred Stock
2021-06-28−0→ 0 total
Conversion
NeueHealth, Inc.$NEUE
Series E Preferred Stock
2021-06-28−0→ 0 total
Purchase
Allena Pharmaceuticals, Inc.
Common Stock
2017-11-06+0→ 0 total
Conversion
Allena Pharmaceuticals, Inc.
Series A Preferred Stock
2017-11-06−0→ 0 total
Conversion
Allena Pharmaceuticals, Inc.
Series B Preferred Stock
2017-11-06−0→ 0 total
Conversion
Allena Pharmaceuticals, Inc.
Common Stock
2017-11-06+0→ 0 total
Award
Tempest Therapeutics, Inc.$TPST
Stock Option (right to buy)
2013-06-07+4,448→ 4,448 total
Conversion
Tempest Therapeutics, Inc.$TPST
Common Stock
2012-08-13+0→ 0 total
Conversion
Tempest Therapeutics, Inc.$TPST
Common Stock
2012-08-13+0→ 0 total
Conversion
Tempest Therapeutics, Inc.$TPST
Series B Preferred Stock
2012-08-13−0→ 0 total
Conversion
Tempest Therapeutics, Inc.$TPST
Series A Preferred Stock
2012-08-13−0→ 0 total
Award
Verastem, Inc.$VSTM
Stock Option (Right to Buy)
2012-03-06+12,500→ 12,500 total
Conversion
Verastem, Inc.$VSTM
Common Stock
2012-02-01+0→ 0 total
Conversion
Verastem, Inc.$VSTM
Common Stock
2012-02-01+0→ 0 total
Conversion
Verastem, Inc.$VSTM
Series C Preferred Stock
2012-02-01−0→ 0 total
Conversion
Verastem, Inc.$VSTM
Series B Preferred Stock
2012-02-01−0→ 0 total
Conversion
Verastem, Inc.$VSTM
Common Stock
2012-02-01+0→ 0 total
Purchase
Verastem, Inc.$VSTM
Common Stock
2012-02-01$10.00/sh+0→ 0 total
Conversion
Verastem, Inc.$VSTM
Series A Preferred Stock
2012-02-01−0→ 0 total

Companies

Recent Filings

Address

C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVENUE, SUITE 104

LARCHMONT, NY, 10538

View on SEC.gov